Investors Sell Shares of CVS Health (CVS) on Strength (CVS)

Traders sold shares of CVS Health Corp (NYSE:CVS) on strength during trading hours on Tuesday. $158.85 million flowed into the stock on the tick-up and $232.20 million flowed out of the stock on the tick-down, for a money net flow of $73.35 million out of the stock. Of all stocks tracked, CVS Health had the 11th highest net out-flow for the day. CVS Health traded up $0.64 for the day and closed at $72.31

A number of research firms recently weighed in on CVS. Royal Bank of Canada began coverage on CVS Health in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target for the company. Jefferies Group increased their price target on CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. Loop Capital began coverage on CVS Health in a research report on Thursday, August 24th. They issued a “hold” rating and a $83.00 price target for the company. Robert W. Baird reiterated a “hold” rating and issued a $77.00 price target on shares of CVS Health in a research report on Friday, October 27th. Finally, Mizuho set a $90.00 price target on CVS Health and gave the company a “buy” rating in a research report on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $86.35.

The firm has a market cap of $73,250.00, a P/E ratio of 12.80, a PEG ratio of 1.37 and a beta of 0.89. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.64 EPS. research analysts anticipate that CVS Health Corp will post 5.9 EPS for the current fiscal year.

In related news, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the completion of the sale, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at approximately $3,504,758.26. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.61% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Fieldpoint Private Securities LLC raised its stake in shares of CVS Health by 333.3% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 1,000 shares in the last quarter. Wealthcare Advisory Partners LLC raised its stake in shares of CVS Health by 330.3% in the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 991 shares in the last quarter. Arcadia Investment Management Corp MI raised its stake in shares of CVS Health by 119.6% in the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after acquiring an additional 726 shares in the last quarter. MPS Loria Financial Planners LLC bought a new position in shares of CVS Health in the 2nd quarter valued at approximately $119,000. Finally, Gemmer Asset Management LLC raised its stake in shares of CVS Health by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 200 shares in the last quarter. 81.63% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Investors Sell Shares of CVS Health (CVS) on Strength (CVS)” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2017/12/19/investors-sell-shares-of-cvs-health-cvs-on-strength-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply